
AIM ImmunoTech AIM
$ 0.7
-0.3%
Quarterly report 2025-Q3
added 11-17-2025
AIM ImmunoTech DSO Ratio 2011-2026 | AIM
Annual DSO Ratio AIM ImmunoTech
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 46 | 0.0761 | 2.14 K | 1.09 K | 20 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.14 K | 0.0761 | 658 |
Quarterly DSO Ratio AIM ImmunoTech
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 80.3 | - | - | - | - | - | - | - | 77.4 | 123 | 111 | - | 86.2 | 77.6 | 79.1 | - | 65.8 | 138 | - | - | 564 | 650 | 211 | - | 24.3 | 10.3 | 13 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 650 | 10.3 | 154 |
DSO Ratio of other stocks in the Biotechnology industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
48.3 | - | -24.86 % | $ 820 K | ||
|
ADMA Biologics
ADMA
|
74.6 | $ 16.49 | -0.3 % | $ 3.93 B | ||
|
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.114 | - | - | $ 26.5 M | ||
|
AbCellera Biologics
ABCL
|
173 | $ 3.59 | -1.1 % | $ 1.07 B | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Apellis Pharmaceuticals
APLS
|
115 | $ 20.5 | 3.22 % | $ 2.59 B | ||
|
Aptorum Group Limited
APM
|
20.6 | $ 0.81 | -1.57 % | $ 4.42 M | ||
|
ANI Pharmaceuticals
ANIP
|
114 | $ 75.14 | -1.82 % | $ 1.45 B | ||
|
Aravive
ARAV
|
16.8 | - | -13.39 % | $ 1.45 M | ||
|
Adverum Biotechnologies
ADVM
|
222 | - | - | $ 86.2 M | ||
|
Athersys
ATHX
|
22.6 | - | 3.77 % | $ 22.4 M | ||
|
AVEO Pharmaceuticals
AVEO
|
47.5 | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
105 | $ 163.09 | -0.61 % | $ 8.11 B | ||
|
Champions Oncology
CSBR
|
66.5 | $ 6.0 | - | $ 82 M | ||
|
BridgeBio Pharma
BBIO
|
52.4 | $ 65.5 | -1.57 % | $ 12.5 B | ||
|
BioDelivery Sciences International
BDSI
|
115 | - | -4.8 % | $ 255 M | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
BeiGene, Ltd.
BGNE
|
52.6 | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
103 | - | -7.31 % | $ 87 M | ||
|
CureVac N.V.
CVAC
|
13.6 | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | ||
|
BioMarin Pharmaceutical
BMRN
|
88.9 | $ 60.3 | -0.22 % | $ 11.6 B | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
4.13 | $ 3.04 | -5.0 % | $ 1.09 M | ||
|
Galmed Pharmaceuticals Ltd.
GLMD
|
33.4 | $ 0.59 | - | $ 549 K | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Capricor Therapeutics
CAPR
|
31.9 | $ 25.56 | 0.22 % | $ 684 M |